» Articles » PMID: 6995513

Autonomic and Behavioral Effects of Dextroamphetamine and Placebo in Normal and Hyperactive Prepubertal Boys

Overview
Publisher Springer
Date 1980 Jun 1
PMID 6995513
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

The hypothesis is tested that the response to dextroamphetamine in terms of activity, attention, impulsivity, and autonomic activity is similar in normal (N) and hyperactive (H) children. Fourteen N and 15 H boys had skin conductance (SC), heart rate (HR), and finger temperature (ST) recorded during rest, presentation of eight 75-dB tones, and a reaction time (RT) procedure on three occasions: off drug (Day 1) and after ingestion (double-blind) of placebo and of .5 mg/kg dextroamphetamine. Both N and H groups showed drug effects, compared to placebo, of reduced motor activity and impulsivity, improved attention (RT), increased HR and HR slowing during RT foreperiods, and decreased ST. Both groups also had decreases in SC responsivity but in different parts of the test. Placebo compared to Day 1 produced increased activity and autonomic "arousal" but no change in Rt. Stimulant drugs thus have similar behavioral and autonomic effects in both N and H boys, but the beneficial effects on behavior do not depend critically on increases in arousal.

Citing Articles

Executive Functions in Alzheimer Disease: A Systematic Review.

Guarino A, Favieri F, Boncompagni I, Agostini F, Cantone M, Casagrande M Front Aging Neurosci. 2019; 10:437.

PMID: 30697157 PMC: 6341024. DOI: 10.3389/fnagi.2018.00437.


Genetic targeting of the amphetamine and methylphenidate-sensitive dopamine transporter: on the path to an animal model of attention-deficit hyperactivity disorder.

Mergy M, Gowrishankar R, Davis G, Jessen T, Wright J, Stanwood G Neurochem Int. 2013; 73:56-70.

PMID: 24332984 PMC: 4177817. DOI: 10.1016/j.neuint.2013.11.009.


Attention-deficit/hyperactivity phenotype in mice lacking the cyclin-dependent kinase 5 cofactor p35.

Drerup J, Hayashi K, Cui H, Mettlach G, Long M, Marvin M Biol Psychiatry. 2010; 68(12):1163-71.

PMID: 20832057 PMC: 2997929. DOI: 10.1016/j.biopsych.2010.07.016.


Adverse effects of pharmacotherapies for attention-deficit hyperactivity disorder: epidemiology, prevention and management.

Graham J, Coghill D CNS Drugs. 2008; 22(3):213-37.

PMID: 18278977 DOI: 10.2165/00023210-200822030-00003.


Hyperactivity and learning deficits in transgenic mice bearing a human mutant thyroid hormone beta1 receptor gene.

McDonald M, Wong R, Goldstein G, Weintraub B, Cheng S, Crawley J Learn Mem. 1999; 5(4-5):289-301.

PMID: 10454355 PMC: 311272.


References
1.
Cohen N, Douglas V . Characteristics of the orienting response in hyperactive and normal children. Psychophysiology. 1972; 9(2):238-45. DOI: 10.1111/j.1469-8986.1972.tb00759.x. View

2.
Satterfield J, DAWSON M . Electrodermal correlates of hyperactivity in children. Psychophysiology. 1971; 8(2):191-7. DOI: 10.1111/j.1469-8986.1971.tb00450.x. View

3.
ZAHN T, Abate F, Little B, Wender P . Minimal brain dysfunction, stimulant drugs, and autonomic nervous system activity. Arch Gen Psychiatry. 1975; 32(3):381-7. DOI: 10.1001/archpsyc.1975.01760210115009. View

4.
MONTAGU J, Swarbrick L . Effect of amphetamines in hyperkinetic children: stimulant of sedative? A pilot study. Dev Med Child Neurol. 1975; 17(3):293-8. DOI: 10.1111/j.1469-8749.1975.tb04665.x. View

5.
ZAHN T, Little B, Wender P . Pupillary and heart rate reactivity in children with minimal brain dysfunction. J Abnorm Child Psychol. 1978; 6(1):135-47. DOI: 10.1007/BF00915789. View